BioCentury
ARTICLE | Company News

GlaxoSmithKline, Altius Institute deal

June 29, 2015 7:00 AM UTC

GlaxoSmithKline signed a 10-year deal with Altius to research technologies and approaches for decoding how genes are controlled and how a cell’s “operating system” functions in health and disease. GSK...